Journal of Clinical Endocrinology & Metabolism, Vol 69, 832-836, Copyright © 1989 by Endocrine Society

ARTICLES

Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity

M Bagnasco, D Venuti, F Paolieri, G Torre, S Ferrini and GW Canonica
Istituto Scientifico di Medicina Interna, Centro di Immunoendocrinologia, University of Genoa, Italy.

We investigated the phenotype and function of thyroid tumor-, metastatic lymph node-, and peripheral blood-derived T lymphocytes of four patients with papillary thyroid cancer. Both phenotypic analysis of freshly isolated cells and clonal analysis, using a high efficiency cloning technique, were performed. For comparison, intrathyroid and peripheral blood T lymphocytes derived from patients with autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis) have been studied. In papillary cancer, the phenotype of thyroid and lymph node-derived T lymphocytes did not differ from that of peripheral blood lymphocytes of the same patients or lymphocytes from normal peripheral blood. At variance with respect to autoimmune thyroid disease, activation markers were poorly represented. The functional analysis of T cell clones showed similar proportions of interleukin-2-producing (helper-inducer) clones in thyroid, lymph node, and peripheral blood, slightly lower than in Hashimoto's thyroiditis and slightly higher than in Graves' disease. With regard to effector function, we found lower proportion of clones with cytolytic activity in a lectin-dependent assay compared to that in Hashimoto's thyroiditis. Interestingly, however, the proportions of cytolytic clones displaying cytolytic activity against the neoplastic cell line K562 (natural killer-like activity) or fresh unrelated tumor cells (lymphokine-activated killer activity) were relatively high in thyroid cancer infiltrates.

This article has been cited by other articles:

				S. H. Wang, Z. Cao, J. M. Wolf, M. Van Antwerp, and J. R. Baker Jr. Death Ligand Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis Endocrinology, November 1, 2005; 146(11): 4721 - 4726. [Abstract] [Full Text] [PDF]

				P. L. Arscott, T. Stokes, A. Myc, T. J. Giordano, N. W. Thompson, and J. R. Baker Jr. Fas (CD95) Expression is Up-Regulated on Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4246 - 4252. [Abstract] [Full Text]

				K.-C. Loh, F. S. Greenspan, F. Dong, T. R. Miller, and P. P. B. Yeo Influence of Lymphocytic Thyroiditis on the Prognostic Outcome of Patients with Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 458 - 463. [Abstract] [Full Text]

				M. Battifora, G. Pesce, F. Paolieri, N. Fiorino, C. Giordano, A. M. Riccio, G. Torre, D. Olive, and M. Bagnasco B7.1 Costimulatory Molecule Is Expressed on Thyroid Follicular Cells in Hashimoto's Thyroiditis, But Not in Graves' Disease J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4130 - 4139. [Abstract] [Full Text]

				K. Kawai, E. Resetkova, T. Enomoto, V. Fornasier, and R. Volpé Is Human Leukocyte Antigen-DR and Intercellular Adhesion Molecule-1 Expression on Human Thyrocytes Constitutive in Papillary Thyroid Cancer? Comparative Studies of Human Thyroid Xenografts in Severe Combined Immunodeficient and Nude Mice J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 157 - 164. [Abstract] [Full Text]